Page last updated: 2024-10-26

valproic acid and Central Pontine Myelinolysis

valproic acid has been researched along with Central Pontine Myelinolysis in 1 studies

Valproic Acid: A fatty acid with anticonvulsant and anti-manic properties that is used in the treatment of EPILEPSY and BIPOLAR DISORDER. The mechanisms of its therapeutic actions are not well understood. It may act by increasing GAMMA-AMINOBUTYRIC ACID levels in the brain or by altering the properties of VOLTAGE-GATED SODIUM CHANNELS.
valproic acid : A branched-chain saturated fatty acid that comprises of a propyl substituent on a pentanoic acid stem.

Research Excerpts

ExcerptRelevanceReference
"The authors describe a case of a drug-associated hyperammonemia, central pontine myelinolysis and coma occurring in a patient with Sjögren's syndrome chronically treated with valproic acid for an underlying psychotic disorder."3.74[Hyperammoniemia and central pontine myelinolysis in a patient with Sjögren syndrome and chronic valproate use]. ( Battaglia, K; Berlot, G; Ukmar, M, 2008)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Berlot, G1
Battaglia, K1
Ukmar, M1

Other Studies

1 other study available for valproic acid and Central Pontine Myelinolysis

ArticleYear
[Hyperammoniemia and central pontine myelinolysis in a patient with Sjögren syndrome and chronic valproate use].
    Recenti progressi in medicina, 2008, Volume: 99, Issue:10

    Topics: Adult; Antimanic Agents; Female; Humans; Hyperammonemia; Myelinolysis, Central Pontine; Sjogren's Sy

2008